Skip to content

Clinical study of balloon- assisted sclerosing agent in the treatment of esophageal varices

Clinical study of balloon- assisted sclerosing agent in the treatment of esophageal varices

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039974
Enrollment
Unknown
Registered
2020-11-15
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal varices

Interventions

Group 1:Balloon assisted sclerotherapy

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Perform medical history inquiry, laboratory examination, endoscopy, liver color Doppler ultrasound examination, etc. who are diagnosed with cirrhosis and esophageal varices; 3. Patients with a history of bleeding from varicose veins and endoscopic balloon-assisted sclerotherapy; 4. The hospital ethics committee approved the research content.

Exclusion criteria

Exclusion criteria: 1. Patients with bleeding in other parts; 2. Patients with gastrointestinal bleeding caused by other reasons; 3. Patients with blood system diseases; 4. Patients with other serious organ complications and malignant tumors;

Design outcomes

Primary

MeasureTime frame
Postoperative bleeding;Varicose vein improvement;Postoperative complications;

Countries

China

Contacts

Public ContactDerun Kong

The First Affiliated Hospital of Anhui Medical University

kongderun168@163.com+86 13955155476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026